Emerging flaviviruses are causative agents of severe and life-threatening diseases, against which no approved therapies are available. Among the nucleoside analogues, which represent a promising group of potentially therapeutic compounds, fluorine-substituted nucleosides are characterized by unique structural and functional properties. Despite having first been synthesized almost 5 decades ago, they still offer new therapeutic opportunities as inhibitors of essential viral or cellular enzymes active in nucleic acid replication/transcription or nucleoside/nucleotide metabolism. Here, we report evaluation of the antiflaviviral activity of 28 nucleoside analogues, each modified with a fluoro substituent at different positions of the ribose ring and/or heterocyclic nucleobase. Our antiviral screening revealed that 3'-deoxy-3'-fluoroadenosine exerted a low-micromolar antiviral effect against tick-borne encephalitis virus (TBEV), Zika virus, and West Nile virus (WNV) (EC50 values from 1.1 ± 0.1 μM to 4.7 ± 1.5 μM), which was manifested in host cell lines of neural and extraneural origin. The compound did not display any measurable cytotoxicity up to concentrations of 25 μM but had an observable cytostatic effect, resulting in suppression of cell proliferation at concentrations of >12.5 μM. Novel approaches based on quantitative phase imaging using holographic microscopy were developed for advanced characterization of antiviral and cytotoxic profiles of 3'-deoxy-3'-fluoroadenosine in vitro In addition to its antiviral activity in cell cultures, 3'-deoxy-3'-fluoroadenosine was active in vivo in mouse models of TBEV and WNV infection. Our results demonstrate that fluoro-modified nucleosides represent a group of bioactive molecules with excellent potential to serve as prospective broad-spectrum antivirals in antiviral research and drug development.

Department of Biomedical Engineering Faculty of Electrical Engineering and Communication Brno University of Technology Brno Czech Republic

Department of Chemistry and Biochemistry Mendel University in Brno Brno Czech Republic

Department of Chemistry and Biochemistry University of Maryland Baltimore County Baltimore Maryland USA

Department of Experimental Biology Masaryk University Brno Czech Republic

Department of Pathological Physiology Faculty of Medicine Masaryk University Brno Czech Republic

Department of Pharmacology and Pharmacy Faculty of Veterinary Medicine University of Verterinary and Pharmaceutical Sciences Brno Brno Czech Republic

Department of Physiology Faculty of Medicine Masaryk University Brno Czech Republic

Department of Virology Veterinary Research Institute Brno Czech Republic

Institute of Parasitology Biology Centre of the Czech Academy of Sciences Ceske Budejovice Czech Republic

Institute of Vertebrate Biology Czech Academy of Sciences Brno Czech Republic

Rega Institute for Medical Research KU Leuven Leuven Belgium

000      

00000naa a2200000 a 4500

001      

bmc21019423

003      

CZ-PrNML

005      

20230808133808.0

007      

ta

008      

210728s2021 xxu f 000 0|eng||

009      

AR

024    7_

$a 10.1128/AAC.01522-20 $2 doi

035    __

$a (PubMed)33229424

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a xxu

100    1_

$a Eyer, Luděk $u Department of Virology, Veterinary Research Institute, Brno, Czech Republic eyer@vri.cz $u Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, Ceske Budejovice, Czech Republic $7 xx0098551

245    10

$a Broad-Spectrum Antiviral Activity of 3'-Deoxy-3'-Fluoroadenosine against Emerging Flaviviruses / $c L. Eyer, P. Svoboda, J. Balvan, T. Vičar, M. Raudenská, M. Štefánik, J. Haviernik, I. Huvarová, P. Straková, I. Rudolf, Z. Hubálek, K. Seley-Radtke, E. de Clercq, D. Růžek

520    9_

$a Emerging flaviviruses are causative agents of severe and life-threatening diseases, against which no approved therapies are available. Among the nucleoside analogues, which represent a promising group of potentially therapeutic compounds, fluorine-substituted nucleosides are characterized by unique structural and functional properties. Despite having first been synthesized almost 5 decades ago, they still offer new therapeutic opportunities as inhibitors of essential viral or cellular enzymes active in nucleic acid replication/transcription or nucleoside/nucleotide metabolism. Here, we report evaluation of the antiflaviviral activity of 28 nucleoside analogues, each modified with a fluoro substituent at different positions of the ribose ring and/or heterocyclic nucleobase. Our antiviral screening revealed that 3'-deoxy-3'-fluoroadenosine exerted a low-micromolar antiviral effect against tick-borne encephalitis virus (TBEV), Zika virus, and West Nile virus (WNV) (EC50 values from 1.1 ± 0.1 μM to 4.7 ± 1.5 μM), which was manifested in host cell lines of neural and extraneural origin. The compound did not display any measurable cytotoxicity up to concentrations of 25 μM but had an observable cytostatic effect, resulting in suppression of cell proliferation at concentrations of >12.5 μM. Novel approaches based on quantitative phase imaging using holographic microscopy were developed for advanced characterization of antiviral and cytotoxic profiles of 3'-deoxy-3'-fluoroadenosine in vitro In addition to its antiviral activity in cell cultures, 3'-deoxy-3'-fluoroadenosine was active in vivo in mouse models of TBEV and WNV infection. Our results demonstrate that fluoro-modified nucleosides represent a group of bioactive molecules with excellent potential to serve as prospective broad-spectrum antivirals in antiviral research and drug development.

650    _2

$a zvířata $7 D000818

650    _2

$a antivirové látky $x farmakologie $7 D000998

650    _2

$a deoxyadenosiny $x farmakologie $7 D003839

650    12

$a viry klíšťové encefalitidy $7 D004669

650    _2

$a myši $7 D051379

650    _2

$a prospektivní studie $7 D011446

650    _2

$a replikace viru $7 D014779

650    12

$a virus zika $7 D000071244

650    12

$a infekce virem zika $7 D000071243

655    _2

$a časopisecké články $7 D016428

655    _2

$a práce podpořená grantem $7 D013485

700    1_

$a Svoboda, Pavel $u Department of Virology, Veterinary Research Institute, Brno, Czech Republic $u Department of Pharmacology and Pharmacy, Faculty of Veterinary Medicine, University of Verterinary and Pharmaceutical Sciences Brno, Brno, Czech Republic

700    1_

$a Balvan, Jan $u Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic $u Department of Chemistry and Biochemistry, Mendel University in Brno, Brno, Czech Republic

700    1_

$a Vičar, Tomáš $u Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic $u Department of Biomedical Engineering, Faculty of Electrical Engineering and Communication, Brno University of Technology, Brno, Czech Republic

700    1_

$a Raudenská, Matina $u Department of Chemistry and Biochemistry, Mendel University in Brno, Brno, Czech Republic $u Department of Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic

700    1_

$a Štefánik, Michal $u Department of Virology, Veterinary Research Institute, Brno, Czech Republic $u Department of Chemistry and Biochemistry, Mendel University in Brno, Brno, Czech Republic

700    1_

$a Haviernik, Jan $u Department of Virology, Veterinary Research Institute, Brno, Czech Republic $u Department of Experimental Biology, Masaryk University, Brno, Czech Republic

700    1_

$a Huvarová, Ivana $u Department of Virology, Veterinary Research Institute, Brno, Czech Republic

700    1_

$a Straková, Petra $u Department of Virology, Veterinary Research Institute, Brno, Czech Republic

700    1_

$a Rudolf, Ivo $u Institute of Vertebrate Biology, Czech Academy of Sciences, Brno, Czech Republic $u Department of Experimental Biology, Masaryk University, Brno, Czech Republic

700    1_

$a Hubálek, Zdeněk $u Institute of Vertebrate Biology, Czech Academy of Sciences, Brno, Czech Republic

700    1_

$a Seley-Radtke, Katherine $u Department of Chemistry and Biochemistry, University of Maryland, Baltimore County, Baltimore, Maryland, USA

700    1_

$a de Clercq, Erik $u Rega Institute for Medical Research, KU Leuven, Leuven, Belgium

700    1_

$a Růžek, Daniel, $u Department of Virology, Veterinary Research Institute, Brno, Czech Republic $u Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, Ceske Budejovice, Czech Republic $d 1981- $7 stk2008441707

773    0_

$w MED00009215 $t Antimicrobial agents and chemotherapy $x 1098-6596 $g Roč. 65, č. 2 (2021)

856    41

$u https://pubmed.ncbi.nlm.nih.gov/33229424 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y p $z 0

990    __

$a 20210728 $b ABA008

991    __

$a 20230808133805 $b ABA008

999    __

$a ok $b bmc $g 1690279 $s 1139869

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2021 $b 65 $c 2 $e 20210120 $i 1098-6596 $m Antimicrobial agents and chemotherapy $n Antimicrob Agents Chemother $x MED00009215

LZP    __

$a Pubmed-20210728